TTK Healthcare's Quarterly Profit More Than Doubles As Sales Rise
India's TTK Healthcare Ltd reported a more than two-fold rise in quarterly profit on Friday, boosted by higher sales of medical devices and contraceptives.
Profit from continuing operations rose to 79.1 million Indian rupees ($959,625.37) for the three months ended Sept. 30, from 37.5 million rupees a year earlier.
Shares of the company rose nearly 3% to hit a two-week high.
The rising prevalence of chronic medical conditions has led to development of various advanced medical treatments, resulting in higher demand for medical devices.
Revenue from operations rose 12.8% to 1.7 billion rupees, helped by a 14.7% increase in revenue in its medical devices segment.
Revenue from its protective devices segment, which houses its Skore condom brand, climbed nearly 33% as it launched new products. Recently, it also won a contract to supply contraceptive devices to an international agency till July 2023.
(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)
-
We May Need Another Tukaram Mundhe To Fight Air Pollution | The Reason Why
Developers may install basic measures such as sprinklers and green nets, resume work, and continue violating rules when this equipment stops working.
-
Extracting Value From Battery Scrap Could Be Challenging For India | The Reason Why
A discarded lithium-ion battery still contains valuable materials such as lithium, nickel and cobalt. These can be recovered and reused. When such batteries are crushed and shredded, they produce a dark powder called black mass.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.